Related Experiment Video
Updated: Jun 8, 2026
08:04
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Primary electrical diseases diagnosis, genetic and management
1Department of Cardiology, University Hospital Rangueil, Toulouse, France. mauryjphil@hotmail.com
Minerva Cardioangiologica
|October 13, 2010
Summary
Primary electrical diseases, or channelopathies, are genetic conditions affecting heart cell electrical activity, causing arrhythmias and sudden death risk. This review details their clinical features, genetics, and treatments.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Primary electrical diseases, known as channelopathies, stem from inherited genetic mutations.
- These mutations alter cellular ion channel function, impacting cardiac electrical activity.
- Channelopathies are a significant cause of inherited cardiac arrhythmias and sudden cardiac death.
Purpose of the Study:
- To provide a comprehensive review of cardiac channelopathies.
- To describe the clinical manifestations, genetic underpinnings, and current therapeutic strategies for these conditions.
Main Methods:
- A descriptive review of the literature on cardiac channelopathies.
- Synthesis of information on clinical presentation, genetic basis, and treatment options.
Main Results:
- Detailed overview of various described channelopathies.
- Emphasis on the link between specific genetic defects and clinical phenotypes.
- Summary of current therapeutic approaches, including pharmacologic and non-pharmacologic interventions.
Conclusions:
- Cardiac channelopathies represent a critical group of inherited cardiovascular diseases.
- Understanding the genotype-phenotype correlations is essential for accurate diagnosis and risk stratification.
- Current therapies aim to manage arrhythmias and reduce the risk of sudden cardiac death in affected individuals.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...